Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

about

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

Item

http://www.wikidata.org/entity/Q50424267

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@en

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@nl

type

Item

label

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@en

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@nl

prefLabel

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@en

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@nl

P1476

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

@en

P2093

B Meder

http://www.w3.org/2001/XMLSchema#string

F Sedaghat-Hamedani

http://www.w3.org/2001/XMLSchema#string

H A Katus

http://www.w3.org/2001/XMLSchema#string

P2860

The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the Art

Atlas of the clinical genetics of human dilated cardiomyopathy

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.

Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.

P304

123-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00059-017-4667-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29260236

http://www.w3.org/2001/XMLSchema#string